WebMD Announces Exploration Of Strategic Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Oil settles lower on peace hopes, Saudi attacks limit losses
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
WebMD (WBMD) PT Raised to $55 at Mizuho Securities Following 4Q Results, Strategic Options
February 17, 2017 5:45 AM ESTMizuho analyst Neil Doshi reiterates Neutral rating and raises price target on WebMd Health Corp. (NASDAQ: WBMD) to $55 (from $52), noting a disappointing outlook and back-end loaded growth, as the company reported 2016 fourth quarter results in-line with estimates, while exploring strategic alternatives.
Doshi... More
WebMD Health (WBMD) Tops Q4 EPS by 7c; Guides Q1, FY17 Revs Below Views
February 16, 2017 4:04 PM ESTWebMD Health (NASDAQ: WBMD) reported Q4 EPS of $0.73, $0.07 better than the analyst estimate of $0.66. Revenue for the quarter came in at $207.5 million versus the consensus estimate of $206.99 million.
GUIDANCE:
WebMD Health sees Q1 revs of $151 million to $154 million versus the... More



